Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • Latest News
    • Different...

    Different antiepileptic drugs and dosages have different teratogenic risks

    Written by Vinay Singh singh Published On 2018-06-14T19:15:44+05:30  |  Updated On 14 Jun 2018 7:15 PM IST
    Different antiepileptic drugs and dosages have different teratogenic risks

    Different antiepileptic drugs and dosages have different teratogenic risks associated with congenital malformations, according to a study recently published in the journal The Lancet Neurology.


    Tomson T et. al conducted a research to compare the occurrence of major congenital malformations following prenatal exposure to the eight most commonly used antiepileptic drugs(AEDs) in monotherapy.


    The researchers did a prospective, longitudinal cohort study based on the EURAP international registry which included 7555 prospective pregnancies. Of those eligible, 7355 pregnancies were exposed to one of the eight antiepileptic drugs. Follow-up data were obtained after each trimester, at birth, and 1 year after birth.


    The primary outcome was to compare the risk of major congenital malformations assessed at 1 year after birth in offspring exposed prenatally to one of eight commonly used antiepileptic drugs (carbamazepine, lamotrigine, levetiracetam, oxcarbazepine, phenobarbital, phenytoin, topiramate, and valproate) and, whenever a dose dependency was identified, to compare the risks at different dose ranges.


    Key findings of the study:




    • With lamotrigine ≤325 mg/day as the comparator, multivariate risk significantly higher for all doses of carbamazepine, valproate, and for phenobarbital >80 mg/day.



    • Prevalence of major congenital malformations: 10.3% for valproate, 6.5% for phenobarbital, 6.4% for phenytoin (Dilantin), 5.5% for carbamazepine (Tegretol, others), 3.9% for topiramate (Topamax, others), 3.0% for oxcarbazepine (Trileptal, others), 2.9% for lamotrigine (Lamictal), 2.8% for levetiracetam (Keppra, others).

    • Dose-response seen for carbamazepine, lamotrigine, phenobarbital, valproate

    • Risk higher with carbamazepine >700 mg/day vs levetiracetam 250-4000 mg/day or oxcarbazepine 75-4500 mg/day

    • Relative to levetiracetam 250-4000 mg/day, valproate ≤650 mg/day increased risk.


    The study concluded that different antiepileptic drugs and dosages have different teratogenic risks. Risks of major congenital malformation associated with lamotrigine, levetiracetam, and oxcarbazepine were within the range for offspring unexposed to antiepileptic drugs. The findings of the study will help the clinicians to rationally select the drugs while taking into account comparative risks associated with treatment alternatives. The study suggested the cautious interpretation of data for topiramate and phenytoin due to the small number of exposures in the study.


    For more reference log on to https://doi.org/10.1016/S1474-4422(18)30107-8
    carbamazepinecongenital malformationsLamictallamotriginelevetiracetammonotherapymultivariate riskoxcarbazepinephenobarbitalphenytoinThe Lancet NeurologytopiramateTrileptalvalproate
    Source : With inputs from the journaljournal The Lancet Neurology

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Vinay Singh singh
    Vinay Singh singh
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok